Biologics Series

: Speakers

Speakers

April 2021 | London, UK

If you are looking for the 2020 event, Biologics Series: Virtual, please click here

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Adam Root

Senior Principal Scientist

Pfizer

Afaf El-Sagheer

Professor

University of Oxford

Albert Isidro Llobet

Associate Fellow and Investigator

GlaxoSmithKline

Alex Batchelor

Chief Executive Officer

Orbit Discovery

Alexander Frey

Associate Professor, Molecular Biotechnology

Aalto University

Ali Tavassoli

Founder and Chief Scientific Officer

Curve Therapeutics

Aline Miller

Professor

University of Manchester

Alistair Henry

Head, Discovery Science

UCB

Andre Cobb

Senior Lecturer in Organic Chemistry

King's College London

Andre Gerber

Professor of RNA Biologiy

University of Surrey

Andreas Hoijer

New Modality Formulation Team Leader

AstraZeneca

Andrew Livingston

Professor of Chemical Engineering

Queen Mary, University of London

Andrew Sanderson

Scientific Leader

GlaxoSmithKline

Andrew Young

Chief Scientific Officer

Intarcia Therapeutics

Annekathrin Haberland

Director, Regulatory Affairs

Berlin Cures

Anup Zutshi

Head of Translational Quantitative Pharmacology-USA

EMD Serono

Bellos Hadjivassiliou

Scientist II

Celgene

Chawaree Chaipan

Investigator II

Novartis

Chengbin Wu

Founder and Chief Executive Offifer

EpimAB Biotherapeutics

Christina Claus

Senior Scientist

Roche Pharmaceutical Research and Early Development (pRED)

Claudio Sustmann

Head Program Management & External Innovation

Large Molecule Research, Roche Pharmaceuticals

Colette Johnston

Senior Director, Early Discovery

Crescendo Biologics

Colin Self

Emeritus Professor

Newcastle University

Darren Bates

Principal Scientist

Amgen

David Earp

President and Chief Executive Officer

Circle Pharma

David Tew

Project Leader and GSK Senior Fellow

GlaxoSmithKline

David Williams

Reader in Chemical Biology

University of Sheffield

Denise Steckel

Head, Clincial Collaborations Management

Genentech

Derek MacMillan

Reader in Organic Chemistry

University College London

E. Sally Ward

Professor

University of Southampton

Ekkehard Leberer

Senior Director

Sanofi

Fabrizio Badalassi

Director Chemical Development

Ferring Pharmaceuticals

Fionnuala McAleese Eser

Antibody Lead Discovery 1

Bayer AG

Francesca Macchi

Scientist

Zealand Pharma

Francisca Wollerton

Director of Antibody Engineering

F-star Biotechnology

Frank Sobott

Chair in Biomolecular Mass Spectrometry

University of Leeds

Frank Thielmann

Operational Excellence Director - Region Europe

Takeda

Galahad Deperalta

Senior Scientist

Genentech

Gemma Mudd

Senior Scientist

Bicycle Therapeutics

Gene Liau

Executive Vice President and Head, Research & Preclinical Development

Stoke Therapeutics

Graham Ogg

Founder

Orbit Discovery

Guy Georges

Senior Principal Scientist

Roche Pharmaceuticals

Haiyan Zhou

Principal Investigator and Group Leader

University College London

Helen Harrison

Group Leader

Bicycle Therapeutics

Henrik Sune Ramírez-Andersen

Scientific Director

Novo Nordisk A/S

Ho Cho

Vice President, Biotherapeutics

Celgene

Inga Nørby

Expression Technologies 2, Director

Novo Nordisk

Itai Benhar

Professor

Tel Aviv University

Jacques Dumas

Head of Protein Sciences & Technology

Sanofi

James Apgar

Senior Principal Scientist

Pfizer

Jennifer Drew

Investigator

GlaxoSmithKline

Jennifer Franklin

Director, CMC Regulatory Affairs

IONIS Pharmaceuticals

Jennifer Fretland

Head of DMPK US

Sanofi

Jerry Heng

Reader in Particle Technology

Imperial College London

Jesper Soendergaard Marino

Principal Scientist

Novo Nordisk

Jesper Wengel

Professor of Nucleic Acid Center

University of Southern Denmark

Jette Boll

Senior Scientist

Ferring

John Blackwood

Senior Research Scientist

Kymab

John Delaney

Director, Research Technologies and Collaborations

Amgen

John McCafferty

Chief Executive Officer

IONTAS Pharmaceuticals

Justin Murray

Principal Scientist

Amgen

Kati Räsänen

Senior Scientist, Biologics

Orion Pharma

Konrad Bleicher

Group Leader, RNA Therapeutics

F.Hoffmann – La Roche

Kristin Brown

Director, Molecular Design US

GlaxoSmithKline

Laura Itzhaki

Chief Scientific Officer

PolyProx Therapeutics

Laura von Schantz

Director, Antibody Engineering

Alligator Bioscience

Lauren Ely

Senior Principal Scientist

Pfizer

Laurence Fayadat-Dilman

Senior Director, Protein Sciences Head, Discovery Biologics

MSD

Li Li

Principal Scientist

Merck

Lorenzo Benatuil

Senior Principal Research Scientist

AbbVie

Magdalena Sips

Senior Scientist

Argenx

Mahendra Deonarain

Chief Executive and Science Officer

Antikor Biopharma

Marc Pompiati

Senior Scientist

Roche Pharmaceuticals

Maria Van Dongen

Head of External Innovation, Discovery Sciences

Janssen

Mark Cragg

Professor of Experimental Cancer Research

University of Southampton

Mark Howarth

Professor

University of Oxford

Mark Throsby

Chief Scientific Officer and Executive Vice President

Merus

Marlon Hinner

Principal Scientist and Group Leader

Roche Pharmaceuticals

Mathias Schaffrath

Group Head Purification

Sanofi

Matthew Catley

Research Director

MiNa Therapeutics

Michael Agrez

Chief Executive Officer

InterK Peptide Therapeutics

Michael Keller

Senior Principal Scientist, Pre-Clinical CMC

F. Hoffmann - La Roche

Nadim Akhtar

Principal Scientist Characterisation & Control Strategy

AstraZeneca

Nicholas Brindle

Professor of Cell Signalling

University of Leicester

Nicolas Fischer

Chief Executive Officer

Light Chain Bioscience – A brand of Novimmune SA

Nigel Richardson

Senior Director, Analytical Chemistry

Former GlaxoSmithkine

Noel Byrne

Expression Group Lead and Associate Principal Scientist

Merck Research Laboratories

Olivier Kitten

Founder and Chief Executive Officer

Affilogic

Patrick Garidel

Head of Process, Purification and Pharma Development

Boehringer Ingelheim

Paul Wassmann

Analytical Strategy & Science Lead

Novartis

Rachel Mulvaney

Senior Scientist

Immunocore

Rajbharan Yadav

Scientist, Development Sciences

Genentech

Ramesh Kumar

Scientist, Formulation and Drug Product Process Development

MedImmune

Rami Hannoush

Principal Scientist

Genentech

Rob De Jong

Associate Director, Antibody Research & Technology

Genmab

Robert Pejchal

Director, Antibody Engineering

Adimab

Robin Löving

Chief Scientific Officer

Salipro Biotech

Sabine Imhof-Jung

Principal Scientist

Roche Pharma

Seema Kumar

Associate Director

MSD

Silvia Sonzini

Senior Scientist

AstraZeneca

Sophia Hober

Professor of Molecular Biotechnology

KTH Royal Institute of Technology

Sophia Karagiannis

Professor of Translational Cancer Immunology and Immunotherapy

King's College London

Stanislas Blein

Vice President, Head of Antibody Engineering

Glenmark Pharmaceuticals

Stefan Zielonka

Associate Director, Protein Engineering & Antibody Technologies

Merck KGaA

Stephan Dickgiesser

Principal Scientist

Merck KGaA

Stephen Ashman

Director, Head of High-Throughput expression and Characterization

GlaxoSmithKline

Steven Ballet

Professor, Departments of Chemistry and Bio-Engineering Sciences

Free University Brussels

Sunay Chankeshwara

Associate Principal Scientist, Senior Expert Peptide Chemistry

AstraZeneca

Surinder Kaur

Director and Senior Scientist in BioAnalytical Sciences/ADT

Genentech

Thomas Vorherr

Director Peptide Discovery

Novartis

Trevor Wilkinson

Associate Director

AstraZeneca

Tristan Vaughan

Vice President R&D, Antibody Discovery & Protein Engineering

AstraZeneca

Victor Terrier

Scientist

Aelin Therapeutics

Vito Fodera

Principal Investigator and Associate Professor of Biophysics

University of Copenhagen

Wendy Sandoval

Principal Scientist

Genentech

William Olson

Senior Vice President

Regeneron

Xiaona Jing

Director, Global CMC And Pharmaceutical Development

NBE Therapeutics

Xin Yu

Senior Scientist

Amgen

Yang Yang

Scientific Technical Leader

Novartis

Youssef Hijazi

DMPK Expert

Sanofi

Zhi Guo

Principal Reseach Scientist I, Global Protein Sciences

AbbVie Research Center